WA’s Brightest Minds Recognised through the 2024 Aspire Awards
By Alicia Bienkowski | Funding, Media Releases, News & Events, ResearchAssociate Professor Elena Juan Pardo, a researcher at the Harry Perkins Institute of Medical Research, is among ten Western Australian recipients of the Business Events Perth 2024 Aspire Awards. The…
New Study Traces Childhood Leukaemia to Genetic Origins Present at Birth
By Alicia Bienkowski | News & EventsA groundbreaking study has revealed a genetic signpost present in blood samples taken at birth that could determine whether or not that child will later develop the most common form…
Perth gains NATA-accreditation for rare disease diagnostic tool
By Richard Schoonraad | Disease Area, Epigenetics and Genomics Laboratory, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, Media Releases, Muscles, Muscular Dystrophy, News & Events, Research, Research AreaResearchers at Perth’s Harry Perkins Institute of Medical Research and PathWest Laboratory Medicine WA are celebrating the long-awaited nationally recognised accreditation of a world-leading diagnostic technology that will provide faster,…
The Harry Perkins Institute of Medical Research family is today remembering Professor Peter Thompson AM, who passed away yesterday. Prof Thompson was past Deputy Director and Laboratory Head of Cardiology…
$10 million raised for WA Cancer Research
By Richard Schoonraad | Cancer, Events, Fundraising, Media Releases, News & Events, Perkins EventsWest Australians give record amount in Australia’s biggest charity ride. This morning it was announced a record $10,104,999 has been raised for WA cancer research by the nation’s biggest charity…
Federal funding helps WA Biotech firm save lives
By Alicia Bienkowski | Disease Area, Funding, Lab, Media Releases, News & Events, Research, Research AreaCytophenix, a WA biotech startup led by Perkins Researcher Dr Kieran Mulroney, has been awarded a $500,000 grant as part of the Brandon BioCatalyst’s CUREator Incubator’s Health Security funding stream. …
Lowering cancer drug dose could open tumours to immunotherapy
By Alicia Bienkowski | Brain, Cancer, Cancer, Disease Area, Lab, Media Releases, Melanoma Discovery, Melonoma, News & Events, Research, Research Area, Systems Biology and GenomicsGroundbreaking research undertaken at the Harry Perkins Institute of Medical Research in Perth has shown that administering anti-cancer drugs at a hundred-fold lower dose than standard protocols could improve the…
Harry Perkins Institute of Medical Research The Perkins conducts innovative research into the diseases that most affect families in the WA community and the world at large. We have grown…